Page last updated: 2024-11-03

ro 31-8220 and Leukemia, Basophilic, Acute

ro 31-8220 has been researched along with Leukemia, Basophilic, Acute in 1 studies

Ro 31-8220: a protein kinase C inhibitor

Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ozawa, K1
Kobayashi, H1
Kawai, E1
Suzaki, E1
Nonomura, Y1
Masujima, T1

Other Studies

1 other study available for ro 31-8220 and Leukemia, Basophilic, Acute

ArticleYear
Quantitative analysis of exocytosis visualized by a video-enhanced light/fluorescence microscope reveals two distinct components of exocytosis in RBL-2H3 cells.
    FEBS letters, 1996, Nov-25, Volume: 398, Issue:1

    Topics: Animals; Antigens; Calcimycin; Dinitrophenols; Enzyme Inhibitors; Exocytosis; Histamine; Image Enhan

1996